These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28520448)

  • 1. [The role of cardiovascular magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Part II].
    Pleva M; Borová J; Plevová I; Januška J; Belicová M
    Vnitr Lek; 2017; 63(4):249-253. PubMed ID: 28520448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological and physiological left ventricular hypertrophy: echocardiography for differentiation.
    Chelliah RK; Senior R
    Future Cardiol; 2009 Sep; 5(5):495-502. PubMed ID: 19715413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of cardiovascular magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Part I].
    Pleva M; Borová J; Plevová I; Januška J; Belicová M
    Vnitr Lek; 2017; 63(3):194-198. PubMed ID: 28379022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Images in cardiovascular medicine. Overlapping phenotypes: left ventricular noncompaction and hypertrophic cardiomyopathy.
    Kelley-Hedgepeth A; Towbin JA; Maron MS
    Circulation; 2009 Jun; 119(23):e588-9. PubMed ID: 19528341
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy: cardiac magnetic resonance imaging changes the paradigm.
    Reichek N; Gupta D
    J Am Coll Cardiol; 2008 Aug; 52(7):567-8. PubMed ID: 18687252
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sigmoid septum: A variant of the ventricular hypertrophy or of the hypertrophic cardiomyopathy?].
    Gentille-Lorente D; Salvadó-Usach T
    Arch Cardiol Mex; 2016; 86(2):110-22. PubMed ID: 27019990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe left ventricular wall thinning and extensive fibrosis without evolution to end stage disease in a patient with hypertrophic cardiomyopathy.
    Assenza GE; Spirito P; Musumeci MB; Lombardi M; Quarta G; Autore C
    J Am Soc Echocardiogr; 2009 Oct; 22(10):1196.e1-2. PubMed ID: 19801310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common presentation of rare diseases: Left ventricular hypertrophy and diastolic dysfunction.
    Linhart A; Cecchi F
    Int J Cardiol; 2018 Apr; 257():344-350. PubMed ID: 29506729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular outflow tract planimetry by cardiovascular magnetic resonance differentiates obstructive from non-obstructive hypertrophic cardiomyopathy.
    Schulz-Menger J; Abdel-Aty H; Busjahn A; Wassmuth R; Pilz B; Dietz R; Friedrich MG
    J Cardiovasc Magn Reson; 2006; 8(5):741-6. PubMed ID: 16891234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.
    Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782
    [No Abstract]   [Full Text] [Related]  

  • 11. Left ventricular hypertrophy diagnosed after a stroke: a case report.
    Umeojiako WI; Kanyal R
    J Med Case Rep; 2018 Mar; 12(1):76. PubMed ID: 29562910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cardiac ultrasound in the assessment of hypertrophic cardiomyopathy.
    Spirito P
    Int J Card Imaging; 1993; 9 Suppl 2():51-3. PubMed ID: 8409553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography.
    Bois JP; Geske JB; Foley TA; Ommen SR; Pellikka PA
    Am J Cardiol; 2017 Feb; 119(4):643-650. PubMed ID: 27956002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
    Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
    Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Olivotto I; Maron MS; Autore C; Lesser JR; Rega L; Casolo G; De Santis M; Quarta G; Nistri S; Cecchi F; Salton CJ; Udelson JE; Manning WJ; Maron BJ
    J Am Coll Cardiol; 2008 Aug; 52(7):559-66. PubMed ID: 18687251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What does the echocardiographer dream - to reach, where sight does not reach].
    Petkow-Dimitrow P
    Kardiol Pol; 2010 Jul; 68(7):769-70. PubMed ID: 20648433
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
    Hinojar R; Fernández-Golfín C; González-Gómez A; Rincón LM; Plaza-Martin M; Casas E; García-Martín A; Fernandez-Mendez MA; Esteban A; Nacher JJJ; Zamorano JL
    Int J Cardiol; 2017 Dec; 249():467-472. PubMed ID: 29121751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential value of myocardial contrast echocardiography for the detection of myocardial fibrosis in hypertrophic cardiomyopathy.
    Chaudeurge A; Garçon P; Cador R
    Arch Cardiovasc Dis; 2011 Dec; 104(12):682-3. PubMed ID: 22152520
    [No Abstract]   [Full Text] [Related]  

  • 19. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
    Kowallick JT; Silva Vieira M; Kutty S; Lotz J; Hasenfu G; Chiribiri A; Schuster A
    Invest Radiol; 2017 Mar; 52(3):177-185. PubMed ID: 27741021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes.
    Cerrato F; Pacileo G; Limongelli G; Gagliardi MG; Santoro G; Digilio MC; Di Salvo G; Ardorisio R; Miele T; Calabrò R
    Cardiol Young; 2008 Dec; 18(6):575-80. PubMed ID: 18842161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.